Cerity Partners’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
26,881
-3,289
-11% -$270K ﹤0.01% 1423
2025
Q4
$2.76M Sell
30,170
-5,857
-16% -$561K ﹤0.01% 1229
2025
Q3
$3.41M Buy
36,027
+8,623
+31% +$812K 0.01% 1040
2025
Q2
$2.87M Buy
27,404
+12,381
+82% +$1.17M 0.01% 1052
2025
Q1
$1.33M Sell
15,023
-1,177
-7% -$121K ﹤0.01% 1305
2024
Q4
$1.53M Sell
16,200
-1,059
-6% -$98.7K ﹤0.01% 1225
2024
Q3
$1.41M Buy
17,259
+2,258
+15% +$174K ﹤0.01% 1252
2024
Q2
$1.29M Sell
15,001
-1,128
-7% -$91.1K ﹤0.01% 1110
2024
Q1
$1.32M Buy
16,129
+767
+5% +$59.9K ﹤0.01% 1151
2023
Q4
$1.02M Sell
15,362
-394
-3% -$27.3K ﹤0.01% 975
2023
Q3
$1.15M Sell
15,756
-1,146
-7% -$77.4K 0.01% 716
2023
Q2
$1.07M Buy
16,902
+546
+3% +$31.7K ﹤0.01% 905
2023
Q1
$960K Sell
16,356
-4,978
-23% -$302K ﹤0.01% 992
2022
Q4
$1.32M Buy
+21,334
New +$1.43M 0.01% 622

Other funds holding HQY

Cerity Partners's HQY Position: Q1 2026 in Review

Cerity Partners reduced its HealthEquity (HQY) stake by 11% in Q1 2026, selling an estimated $270K and leaving 26,881 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Cerity Partners first reported a position in HQY in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.41M in Q3 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Cerity Partners held 26,881 shares of HealthEquity worth $2.25M as of Q1 2026.
  • Cerity Partners sold 3,289 HealthEquity shares in Q1 2026, an estimated $270K.
  • HealthEquity made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1423 holding.
  • Cerity Partners first reported a position in HealthEquity in Q4 2022 and has held it in 14 quarters since.
  • Cerity Partners's HealthEquity position peaked at $3.41M in Q3 2025.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.